申请人:Eli Lilly and Company
公开号:US05874427A1
公开(公告)日:1999-02-23
This invention provides novel 5-HT.sub.1F agonists of the Formula ##STR1## in which X, Y, E, R, A, B, and n are as defined in the specification, which are useful for the treatment of migraine and associated disorders.
本发明提供了一种新颖的5-HT.sub.1F激动剂,其化学式为##STR1## 其中X,Y,E,R,A,B和n如规范中所定义,可用于治疗偏头痛及相关疾病。